{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:58:16Z","timestamp":1773417496578,"version":"3.50.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychol."],"abstract":"<jats:p>Persistent physical symptoms have a high prevalence and a large impact for patients and society. To date, treatment effects for these symptoms are often limited. Nocebo effects (i.e., negative outcomes that are not attributable to active treatment components) have a substantial influence on treatment success and can be established via learning through classical conditioning. Therefore, interventions aimed at reducing nocebo effects by means of counterconditioning, in which an alternative association (inhibiting the previous association) is learned, could be a promising method for improving physical symptoms. In experimental studies, counterconditioning has been shown promising in reducing experimentally-induced nocebo effects on pain and itch. Application of counterconditioning procedures to reduce nocebo effects on clinical symptoms has yet to be researched. This paper provides a protocol of a 6-week counterconditioning intervention aimed at reducing nocebo effects and clinical pain in patients with fibromyalgia. A study in patients with fibromyalgia is proposed to examine the feasibility and potential effectiveness of this counterconditioning intervention as a novel treatment method for reducing nocebo effects and generalization to clinical pain symptoms. Results can help design an optimized treatment protocol for reducing nocebo effects, based on the experiences of participants and the first indications of treatment efficacy.<\/jats:p>","DOI":"10.3389\/fpsyg.2022.806409","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T16:38:43Z","timestamp":1655138323000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Counterconditioning as Treatment to Reduce Nocebo Effects in Persistent Physical Symptoms: Treatment Protocol and Study Design"],"prefix":"10.3389","volume":"13","author":[{"given":"Simone","family":"Meijer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri\u00ebt","family":"van Middendorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaya J.","family":"Peerdeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea W. M.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181856","article-title":"Classical conditioning without verbal suggestions elicits placebo analgesia and nocebo hyperalgesia.","volume":"12","author":"Ba\u0327bel","year":"2017","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jama.287.5.622","article-title":"Nonspecific medication side effects and the nocebo phenomenon.","volume":"287","author":"Barsky","year":"2002","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091727","article-title":"Role of conditioning and verbal suggestion in placebo and nocebo effects on itch.","volume":"9","author":"Bartels","year":"2014","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182959","article-title":"Minimizing nocebo effects by conditioning with verbal suggestion: a randomized clinical trial in healthy humans.","volume":"12","author":"Bartels","year":"2017","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1523\/JNEUROSCI.23-10-04315.2003","article-title":"Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo\/nocebo responses.","volume":"23","author":"Benedetti","year":"2003","journal-title":"J. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6841985","article-title":"The underestimated significance of conditioning in placebo hypoalgesia and nocebo hyperalgesia.","volume":"2018","author":"Br\u00e4scher","year":"2018","journal-title":"Pain Res. Manage."},{"key":"B7","first-page":"728","article-title":"The fibromyalgia impact questionnaire: development and validation.","volume":"18","author":"Burckhardt","year":"1991","journal-title":"J. Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1097\/j.pain.0000000000000700","article-title":"Open-label placebo treatment in chronic low back pain: a randomized controlled trial.","volume":"157","author":"Carvalho","year":"2016","journal-title":"Pain"},{"key":"B9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jpain.2017.12.006","article-title":"Autonomic arousal as a mechanism of the persistence of nocebo hyperalgesia.","volume":"19","author":"Colagiuri","year":"2018","journal-title":"J. Pain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jpain.2015.06.012","article-title":"Nocebo hyperalgesia, partial reinforcement, and extinction.","volume":"16","author":"Colagiuri","year":"2015","journal-title":"J. Pain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jama.2012.115","article-title":"Nocebo effects, patient-clinician communication, and therapeutic outcomes.","volume":"307","author":"Colloca","year":"2012","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.pain.2010.08.007","article-title":"How the number of learning trials affects placebo and nocebo responses.","volume":"151","author":"Colloca","year":"2010","journal-title":"Pain"},{"key":"B13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.pain.2008.02.006","article-title":"The role of learning in nocebo and placebo effects.","volume":"136","author":"Colloca","year":"2008","journal-title":"Pain"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0005-7967(99)00135-7","article-title":"Counterconditioning in the treatment of spider phobia: effects on disgust, fear and valence.","volume":"38","author":"De Jong","year":"2000","journal-title":"Behav. Res. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1037\/ccp0000298","article-title":"Exposure and CBT for chronic back pain: an RCT on differential efficacy and optimal length of treatment.","volume":"86","author":"Glombiewski","year":"2018","journal-title":"J. Consult. Clin. Psychol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S1521-6942(03)00036-6","article-title":"Evoked pain measures in fibromyalgia.","volume":"17","author":"Gracely","year":"2003","journal-title":"Best Pract. Res."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbtep.2020.101601","article-title":"Enhancing extinction with response prevention via imagery-based counterconditioning: results on conditioned avoidance and distress.","volume":"70","author":"Hendrikx","year":"2021","journal-title":"J. Behav. Ther. Exp. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pain.2009.03.018","article-title":"Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain.","volume":"144","author":"Jensen","year":"2009","journal-title":"PAIN\u00ae"},{"key":"B19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1037\/xan0000272","article-title":"Retroactive interference: counterconditioning and extinction with and without biologically significant outcomes.","volume":"46","author":"Jozefowiez","year":"2020","journal-title":"J. Exp. Psychol. Anim. Learn. Cogn."},{"key":"B20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.brat.2018.06.009","article-title":"Reduced return of threat expectancy after counterconditioning versus extinction.","volume":"108","author":"Kang","year":"2018","journal-title":"Behav. Res. Ther."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015591","article-title":"Placebos without deception: a randomized controlledtrial in irritable bowel syndrome.","volume":"5","author":"Kaptchuk","year":"2010","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2019.103532","article-title":"Behavioral and neural processes in counterconditioning: past and future directions.","volume":"125","author":"Keller","year":"2020","journal-title":"Behav. Res. Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1097\/j.pain.0000000000001683","article-title":"Effects of open-label placebo on pain, functional disability, and spine mobility in patients with chronic back pain: a randomized controlled trial.","volume":"160","author":"Kleine-Borgmann","year":"2019","journal-title":"Pain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.pain.2007.12.009","article-title":"Exposure in vivo versus operant graded activity in chronic low back pain patients: results of a randomized controlled trial.","volume":"138","author":"Leeuw","year":"2008","journal-title":"Pain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1097\/j.pain.0000000000002234","article-title":"Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial.","volume":"162","author":"Lembo","year":"2021","journal-title":"Pain"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1097\/j.pain.0000000000001012","article-title":"Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia.","volume":"158","author":"Locher","year":"2017","journal-title":"Pain"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000699","article-title":"How to prevent, minimize, or extinguish nocebo effects in pain: a narrative review on mechanisms, predictors, and interventions.","volume":"4","author":"Mana\u00ef","year":"2019","journal-title":"Pain Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.2044-8260.1992.tb00997.x","article-title":"The development of a six-item short-form of the state scale of the Spielberger State\u2014Trait Anxiety Inventory (STAI).","volume":"31","author":"Marteau","year":"1992","journal-title":"Br. J. Clin. Psychol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/PSY.0000000000000743","article-title":"Antipruritic placebo effects by conditioning H1-antihistamine.","volume":"81","author":"Meeuwis","year":"2019","journal-title":"Psychosom. Med."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.31234\/osf.io\/uhd3s","article-title":"Efficacy of open-label counterconditioning for reducing nocebo-effects on pressure pain.","author":"Meijer","year":"2021","journal-title":"PsyArXiv[Preprint]"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jpain.2015.09.007","article-title":"Comparing counterconditioning and extinction as methods to reduce fear of movement-related pain.","volume":"16","author":"Meulders","year":"2015","journal-title":"J. Pain"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020262","article-title":"Deception in research on the placebo effect.","volume":"2","author":"Miller","year":"2005","journal-title":"PLoS Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0005-7894(02)80035-1","article-title":"Treatment context and return of fear in spider phobia.","volume":"33","author":"Mystkowski","year":"2002","journal-title":"Behav. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1097\/j.pain.0000000000002199","article-title":"Underpredicting pain: an experimental investigation into the benefits and risks.","volume":"162","author":"Peerdeman","year":"2021","journal-title":"Pain"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2016.01270","article-title":"An integrative review of the influence of expectancies on pain.","volume":"7","author":"Peerdeman","year":"2016","journal-title":"Front. Psychol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0304-3959(03)00204-5","article-title":"Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation.","volume":"105","author":"Petzke","year":"2003","journal-title":"Pain"},{"key":"B37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/bs.irn.2018.01.011","article-title":"Using learning strategies to inhibit the nocebo effect.","volume":"138","author":"Quinn","year":"2018","journal-title":"Int. Rev. Neurobiol."},{"key":"B38","first-page":"6","article-title":"The code of medical ethics of the american medical association.","volume":"5","author":"Riddick","year":"2003","journal-title":"Ochsner. J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0005-7967(98)00106-5","article-title":"Context-specificity of relapse: effects of therapist and environmental context on return of fear.","volume":"37","author":"Rodriguez","year":"1999","journal-title":"Behav. Res. Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2214.2007.00797.x","article-title":"Open-label use of placebos in the treatment of ADHD: a pilot study.","volume":"34","author":"Sandler","year":"2008","journal-title":"Child"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192758","article-title":"Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis.","volume":"13","author":"Schaefer","year":"2018","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1037\/\/0022-3514.67.6.1063","article-title":"Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test.","volume":"67","author":"Scheier","year":"1994","journal-title":"J. Pers. Soc. Psychol."},{"key":"B43","author":"Spielberger","year":"1983","journal-title":"Manual for the State-Trait Anxiety Inventory (Form Y1 \u2013 Y2)."},{"key":"B44","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The pain catastrophizing scale: development and validation.","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychol. Assess."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/j.pain.0000000000001861","article-title":"Learning mechanisms in nocebo hyperalgesia: the role of conditioning and extinction processes.","volume":"161","author":"Thomaidou","year":"2020","journal-title":"Pain"},{"key":"B46","doi-asserted-by":"publisher","first-page":"103416","DOI":"10.1016\/j.brat.2019.103416","article-title":"Reducing negative stimulus valence does not attenuate the return of fear: two counterconditioning experiments.","volume":"120","author":"Van Dis","year":"2019","journal-title":"Behav. Res. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.brat.2004.01.001","article-title":"Return of fear in a human differential conditioning paradigm caused by a return to the original acquistion context.","volume":"43","author":"Vansteenwegen","year":"2005","journal-title":"Behav. Res. Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pain.2009.04.008","article-title":"Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007.","volume":"145","author":"Vase","year":"2009","journal-title":"PAIN\u00ae"},{"key":"B49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-clinpsy-050212-185542","article-title":"Fear extinction and relapse: state of the art.","volume":"9","author":"Vervliet","year":"2013","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The american college of rheumatology 1990 criteria for the classification of fibromyalgia.","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum."},{"key":"B51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.pain.2007.06.037","article-title":"Evaluating the efficacy of graded in vivo exposure for the treatment of fear in patients with chronic back pain: a randomized controlled clinical trial.","volume":"136","author":"Woods","year":"2008","journal-title":"Pain"}],"container-title":["Frontiers in Psychology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2022.806409\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T16:38:49Z","timestamp":1655138329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2022.806409\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":51,"alternative-id":["10.3389\/fpsyg.2022.806409"],"URL":"https:\/\/doi.org\/10.3389\/fpsyg.2022.806409","relation":{},"ISSN":["1664-1078"],"issn-type":[{"value":"1664-1078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"article-number":"806409"}}